Sth Korea Launches Medicine Reform Commission

9 December 1996

In South Korea, the government has set up a commission to push for reforms in medicine and public health, which is inaugurated as an advisory body to the Prime Minister, reports Korea Newsreview. The Commission is comprised of 30 members, including government officials, medical experts, lawyers and consumers, and its remit is to "find ways to meet public demands for better medical services," an official said after the first meeting of the group.

The Commission, set up as five subgroups, will discuss short- and long-term objectives. As far as the first is concerned, the focus will be on the reinforcement of emergency systems, the improvement of state-administered tests and financial incentives for medical organizations.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight